[Topic silver sulfadiazine bicytopenia: first case].
Blangy
H
H
Service de Pharmacologie clinique et de Toxicologie, Centre Régional de Pharmacovigilance de Lorraine, CHU de Nancy, Nancy, France.
Simon
D
D
Lévy-Cloez
A
A
Feillet
F
F
Fyad
J P
JP
Tréchot
P
P
Gillet
P
P
Lascombes
P
P
D000891:Anti-Infective Agents, Local / Q000008:administration & dosage / Q000009:adverse effects*; D017809:Fatal Outcome; D006801:Humans; D007223:Infant; D008297:Male; D009503:Neutropenia / Q000139:chemically induced* / Q000473:pathology*; D012837:Silver Sulfadiazine / Q000008:administration & dosage / Q000009:adverse effects*
D000891:Anti-Infective Agents, Local; D012837:Silver Sulfadiazine